EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients: how do we interpret the clinical and biomarker data?
Authors
Califano, RaffaeleBlackhall, Fiona H
Finocchiaro, Giovanna
Toschi, Luca
Thatcher, Nick
Cappuzzo, Federico
Crinò, Lucio
Affiliation
Medical Oncology, Ospedale Santa Maria della Misericordia, Perugia, Italy.Issue Date
2008-07-08
Metadata
Show full item recordCitation
EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients: how do we interpret the clinical and biomarker data? 2008, 3 (3):173 Targeted OncologyJournal
Targeted OncologyDOI
10.1007/s11523-008-0084-7Additional Links
http://www.springerlink.com/index/10.1007/s11523-008-0084-7Type
ArticleLanguage
enISSN
1776-25961776-260X
ae974a485f413a2113503eed53cd6c53
10.1007/s11523-008-0084-7